Molecular docking, synthesis, and biological evaluation of naphthoquinone as potential novel scaffold for H5N1 neuraminidase inhibition

References

• Babu, Y. S., Chand, P., Bantia, S., Kotian, P., Dehghani, A., & El-Kattan, Y. (2000). BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. Journal of Medicinal Chemistry, 43, 3482–3486.10.1021/jm0002679
   PubMed Web of Science ®Google Scholar
• Dao, T. T., Tung, B. T., Nguyen, P. H., Thuong, P. T., Yoo, S. S., & Kim, E. H. (2010). C-methylated flavonoids from cleistocalyx operculatus and their inhibitory effects on novel influenza A (H1N1) neuraminidase. Journal of Natural Products, 73, 1636–1642.10.1021/np1002753
   PubMed Web of Science ®Google Scholar
• Eldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V., & Mee, R. P. (1997). Empirical scoring functions.1. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of Computer-Aided Molecular Design, 11, 425–445. doi:10.1023/A:1007996124545.
   PubMed Web of Science ®Google Scholar
• Fajardo-Dolci, G., Gutierrez-Vega, R., Arboleya-Casanova, H., Villalobos, A., Wilson, K. S., & Garcia, S. G. (2010). Clinical characteristics of fatalities due to influenza A (H1N1) virus in Mexico. Thorax, 65, 505–509.10.1136/thx.2009.126953
   PubMed Web of Science ®Google Scholar
• Gong, J. Z., Xu, W. F., & Zhang, J. (2007). Structure and functions of influenza virus neuraminidase. Current Medicinal Chemistry, 14, 113–122.10.2174/092986707779313444
   PubMed Web of Science ®Google Scholar
• Grienke, U., Schmidtke, M., Kirchmair, J., Pfarr, K., Wutzler, P., & Dürrwald, R. (2010). Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from alpinia katsumadai. Journal of Medicinal Chemistry, 53, 778–786.10.1021/jm901440f
   PubMed Web of Science ®Google Scholar
• Grienke, U., Schmidtke, M., von Grafenstein, S., Kirchmair, J., Liedl, K. R., & Rollinger, J. M. (2012). Influenza neuraminidase: A druggable target for natural products. Natural Product Reports, 29, 11–36.10.1039/C1NP00053E
   PubMed Web of Science ®Google Scholar
• Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000). Influenza virus neuraminidase inhibitors. The Lancet, 355, 827–835.10.1016/S0140-6736(99)11433-8
   PubMed Web of Science ®Google Scholar
• Hariono, M., Abdullah, N., Damodaran, K. V., Kamarulzaman, E. E., Mohamed, N., & Syed Hassan, S. … Wahab, H. A. (2016). Potential new H1N1 neuraminidase inhibitors from ferulic acid and vanillin: Molecular modeling, synthesis and in vitro assay. Scientific Reports, 6, 38692.
   PubMed Web of Science ®Google Scholar
• Horimoto, T., & Kawaoka, Y. (2001). Pandemic threat posed by avian influenza A viruses. Clinical Microbiology Reviews, 14(1), 129-+.
   PubMed Web of Science ®Google Scholar
• Hurt, A. C., Holien, J. K., & Barr, I. G. (2009). In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrobial Agents and Chemotherapy, 53, 4433–4440.10.1128/AAC.00334-09
   PubMed Web of Science ®Google Scholar
• Ikram, N. K. K., Durrant, J. D., Muchtaridi, M., Zalaludin, A. S., Purwitasari, N., & Mohamed, N. (2015). A virtual screening approach for identifying plants with anti H5N1 neuraminidase activity. Journal of Chemical Information and Modeling, 55, 308–316.10.1021/ci500405g
   PubMed Web of Science ®Google Scholar
• Jones, G., Willett, P., & Glen, R. C. (1995). Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. Journal of Molecular Biology, 245, 43–53.10.1016/S0022-2836(95)80037-9
   PubMed Web of Science ®Google Scholar
• Kim, J. Y., Jeong, H. J., Park, J. Y., Kim, Y. M., Park, S. J., & Cho, J. K. (2012). Selective and slow-binding inhibition of shikonin derivatives isolated from Lithospermum erythrorhizon on glycosyl hydrolase 33 and 34 sialidases. Bioorganic & Medicinal Chemistry, 20, 1740–1748.10.1016/j.bmc.2012.01.011
   PubMed Web of Science ®Google Scholar
• Laver, G., & Garman, E. (2002). Pandemic influenza: Its origin and control. Microbes and Infection, 4, 1309–1316.10.1016/S1286-4579(02)00013-8
   PubMed Web of Science ®Google Scholar
• Li, X. F., Ohtsuki, T., Shindo, S., Sato, M., Koyano, T., & Preeprame, S. (2007). Mangiferin identified in a screening study guided by neuraminidase inhibitory activity. Planta Medica, 73, 1195–1196.10.1055/s-2007-981582
   PubMed Web of Science ®Google Scholar
• Liu, A. L., Wang, H. D., Lee, S. M. Y., Wang, Y. T., & Du, G. H. (2008). Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorganic & Medicinal Chemistry, 16, 7141–7147.10.1016/j.bmc.2008.06.049
   PubMed Web of Science ®Google Scholar
• Mazumder, A., Wang, S. M., Neamati, N., Nicklaus, M., Sunder, S., & Chen, J. (1996). Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. Journal of Medicinal Chemistry, 39, 2472–2481.10.1021/jm960074e
   PubMed Web of Science ®Google Scholar
• Mercader, A. G., & Pomilio, A. B. (2010). QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. European Journal of Medicinal Chemistry, 45, 1724–1730.10.1016/j.ejmech.2010.01.005
   PubMed Web of Science ®Google Scholar
• Murray, C. W., Auton, T. R., & Eldridge, M. D. (1998). Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model. Journal of Computer-Aided Molecular Design, 12, 503–519. doi:10.1023/A:1008040323669
   PubMed Web of Science ®Google Scholar
• Nicholson, K. G. (1996). Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiology and Infection, 116, 51–63.10.1017/S0950268800058957
   PubMed Web of Science ®Google Scholar
• Platis, D., Smith, B. J., Huyton, T., & Labrou, N. E. (2006). Structure-guided design of a novel class of benzyl-sulfonate inhibitors for influenza virus neuraminidase. Biochemical Journal, 399, 215–223.10.1042/BJ20060447
   PubMed Web of Science ®Google Scholar
• Potier, M., Mameli, L., Bélisle, M., Dallaire, L., & Melançon, S. B. (1979). Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate. Analytical Biochemistry, 94, 287–296.10.1016/0003-2697(79)90362-2
   PubMed Web of Science ®Google Scholar
• Russell, R. J., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., & Blackburn, G. M. (2006). The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature, 443, 45–49.10.1038/nature05114
   PubMed Web of Science ®Google Scholar
• Ryu, Y. B., Kim, J. H., Park, S. J., Chang, J. S., Rho, M. C., & Bae, K. H. (2010). Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorganic & Medicinal Chemistry Letters, 20, 971–974.10.1016/j.bmcl.2009.12.106
   PubMed Web of Science ®Google Scholar
• Sharma, G., Chowdhury, S., Sinha, S., Majumder, H. K., & Kumar, S. V. (2014). Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 29, 185–189.10.3109/14756366.2013.765413
   PubMed Web of Science ®Google Scholar
• Singh, S., Jedrzejas, M. J., Air, G. M., Luo, M., Laver, W. G., & Brouillette, W. J. (1995). Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. Journal of Medicinal Chemistry, 38, 3217–3225.10.1021/jm00017a005
   PubMed Web of Science ®Google Scholar
• Skehel, J. J., & Wiley, D. C. (2000). Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annual Review of Biochemistry, 69, 531–569. doi:69/1/531 [pii]. 10.1146/annurev.biochem.69.1.531
   PubMed Web of Science ®Google Scholar
• Stephenson, I., Democratis, J., Lackenby, A., McNally, T., Smith, J., & Pareek, M. (2009). Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clinical Infectious Diseases, 48, 389–396.10.1086/597429
   PubMed Web of Science ®Google Scholar
• Stoll, V., Stewart, K. D., Maring, C. J., Muchmore, S., Giranda, V., & Gu, Y. G. Y. (2003). Influenza neuraminidase inhibitors:  Structure-based design of a novel inhibitor Series. Biochemistry, 42, 718–727.10.1021/bi0205449
   PubMed Web of Science ®Google Scholar
• Sugaya, N., & Ohashi, Y. (2010). Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrobial Agents and Chemotherapy, 54, 2575–2582.10.1128/AAC.01755-09
   PubMed Web of Science ®Google Scholar
• Sugaya, N., Kohno, S., Ishibashi, T., Wajima, T., & Takahashi, T. (2012). Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection. Antimicrobial Agents and Chemotherapy, 56, 369–377.10.1128/AAC.00132-11
   PubMed Web of Science ®Google Scholar
• Tisseh, Z. N., & Bazgir, A. (2009). An efficient, clean synthesis of 3,3′-(arylmethylene)bis(2-hydroxynaphthalene-1,4-dione) derivatives. Dyes and Pigments, 83, 258–261.10.1016/j.dyepig.2008.09.003
   Web of Science ®Google Scholar
• Varghese, J. N., Mckimmbreschkin, J. L., Caldwell, J. B., Kortt, A. A., & Colman, P. M. (1992). The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins-Structure Function and Genetics, 14, 327–332.10.1002/(ISSN)1097-0134
   PubMed Web of Science ®Google Scholar
• Wang, G. T., Chen, Y. W., Wang, S., Gentles, R., Sowin, T., & Kati, W. (2001). Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores. Journal of Medicinal Chemistry, 44, 1192–1201.10.1021/jm000468c
   PubMed Web of Science ®Google Scholar
• Wang, G. T., Wang, S., Gentles, R., Sowin, T., Maring, C. J., & Kempf, D. J. (2005). Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core. Bioorganic & Medicinal Chemistry Letters, 15, 125–128.10.1016/j.bmcl.2004.10.022
   PubMed Web of Science ®Google Scholar
• Yusuf, M., Konc, J., Sy Bing, C., Trykowska Konc, J., Ahmad Khairudin, N. B., & Janezic, D. (2013). Structurally conserved binding sites of hemagglutinin as targets for influenza drug and vaccine development. Journal of Chemical Information and Modeling, 53, 2423–2436. doi:10.1021/ci400421e
   PubMed Web of Science ®Google Scholar
• Yusuf, M., Mohamed, N., Mohamad, S., Janezic, D., Damodaran, K. V., & Wahab, H. A. (2016). H274Y’s effect on oseltamivir resistance: What happens before the drug enters the binding site. Journal of Chemical Information and Modeling, 56, 82–100.10.1021/acs.jcim.5b00331
   PubMed Web of Science ®Google Scholar
• Zhang, L., Cheng, Y. X., Liu, A. L., Wang, H. D., Wang, Y. L., & Du, G. H. (2010). Antioxidant, anti-inflammatory and anti-influenza properties of components from chaenomeles speciosa. Molecules, 15, 8507–8517.10.3390/molecules15118507
   PubMed Web of Science ®Google Scholar